Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Virios Therapeutics Inc fell by 3.71m. Cash Flow from Financing totalled 1.16m or -- of revenues. In addition the company used 4.87m for operations while cash used for investing totalled .
Cash flow per share | -0.0603 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.113 |
---|---|
Tangible book value per share | 0.113 |
More ▼
Balance sheet in USDView more
Current ratio | 7.27 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼